Related Experiment Video
Updated: May 11, 2026

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Interplay Between Traditional and Scientific Knowledge: Phytoconstituents and Their Roles in Lung and Colorectal
Ilma Imtiaz1, Janet Schloss1, Andrea Bugarcic1
1National Centre for Naturopathic Medicine, Faculty of Health, Southern Cross University, Military Road, Lismore, NSW 2480, Australia.
Natural compounds from eleven medicinal plants show promise in treating lung and colorectal cancers by modulating key cellular pathways. Research integrates traditional knowledge with modern science to overcome challenges like bioavailability for improved cancer therapeutics.
Area of Science:
- Integrative oncology and phytochemistry.
- Exploration of natural products for cancer therapy.
Background:
- Natural plant products have historical and ongoing significance in cancer treatment.
- Lung and colorectal cancers remain under-researched with poor prognoses.
- Limited investigation into the effects of medicinal plants on specific cancer pathways.
Purpose of the Study:
- To review lung and colorectal cancer signaling pathways modulated by bioactive compounds from eleven traditional medicinal plants.
- To identify phytoconstituents with anticancer properties and their mechanisms of action.
- To explore the integration of traditional knowledge with modern strategies for enhanced cancer therapeutics.
Main Methods:
- Literature review focusing on eleven selected traditional medicinal plants.
- Cross-referencing traditional uses with scientific literature on anticancer properties.
- Analysis of in vitro studies on phytoconstituents modulating key cancer signaling pathways (PI3K/Akt/mTOR, RAS/RAF/MAPK, Wnt/β-catenin, TGF-β).
Main Results:
- Several isolated phytoconstituents (e.g., curcumin, baicalin, sanguinarine) demonstrate anticancer effects by modulating critical signaling pathways.
- Bioavailability challenges for compounds like curcumin and baicalin may be addressed through formulation or microbiome interactions.
- Herbal extracts from Echinacea, Glycyrrhiza, and Codonopsis are currently in clinical trials for cancer treatment.
Conclusions:
- Bioactive compounds from traditional medicinal plants offer a promising avenue for novel anticancer drug development.
- Modulation of key cancer signaling pathways and miRNA pathways by these compounds highlights their therapeutic potential.
- The synergy between traditional knowledge, scientific innovation, and technological advancements is crucial for developing effective cancer therapeutics.
More Related Videos
06:24Establishment of Coloproctitis Cancer Model in Mice and Evaluation of Therapeutic Effect of Chinese Medicine
Published on: October 13, 2023
10:21Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
Published on: September 20, 2024
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Cancer Prevention
Some...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Non-Canonical Wnt Signaling Pathways
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cell Signaling in Plants